Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors

Purpose of Review In recent years, immune checkpoint inhibitors have been increasingly used in patients with metastatic cancers with favorable oncological outcomes; however, there have also been increasing number of cancer survivors who have developed immune-related adverse events. Little is known a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current neurology and neuroscience reports 2018-10, Vol.18 (10), p.63-9, Article 63
Hauptverfasser:	Kao, Justin C., Brickshawana, Adipong, Liewluck, Teerin
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Autoimmune diseases Cell death Clinical deterioration Creatine kinase Guillain-Barre syndrome Heart diseases Immune checkpoint inhibitors Immunotherapy Inflammatory diseases Medicine Medicine & Public Health Metastases Monoclonal antibodies Musculoskeletal diseases Myasthenia gravis Myocarditis Nerve and Muscle (L H Weimer Neurology Neuromuscular diseases Neuromuscular junctions Neurosciences Panic attacks PD-1 protein Section Editor Serum levels Targeted cancer therapy Topical Collection on Nerve and Muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!